Details for Patent: 9,399,774
✉ Email this page to a colleague
Which drugs does patent 9,399,774 protect, and when does it expire?
Patent 9,399,774 protects TEGSEDI and is included in one NDA.
This patent has thirty-three patent family members in twenty-four countries.
Summary for Patent: 9,399,774
| Title: | Modulation of transthyretin expression |
| Abstract: | Provided herein are methods, compounds, and compositions for reducing expression of transthyretin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate transthyretin amyloidosis, or a symptom thereof. |
| Inventor(s): | Monia; Brett P. (Encinitas, CA), Freier; Susan M. (San Diego, CA), Siwkowski; Andrew M. (Carlsbad, CA), Guo; Shuling (Carlsbad, CA) |
| Assignee: | Ionis Pharmaceuticals, Inc. (Carlsbad, CA) |
| Application Number: | 14/717,746 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,399,774
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,399,774
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2563920 | ⤷ Sign Up | 300963 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2563920 | ⤷ Sign Up | CA 2019 00001 | Denmark | ⤷ Sign Up |
| European Patent Office | 2563920 | ⤷ Sign Up | 122019000001 | Germany | ⤷ Sign Up |
| European Patent Office | 2563920 | ⤷ Sign Up | PA2019001 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2563920 | ⤷ Sign Up | 2019C/001 | Belgium | ⤷ Sign Up |
| European Patent Office | 2563920 | ⤷ Sign Up | LUC00096 | Luxembourg | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
